Literature DB >> 22773796

Ten years of progress in head and neck cancers.

Shrujal Baxi, Matthew Fury, Ian Ganly, Shyam Rao, David G Pfister.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22773796      PMCID： PMC3708312          DOI： 10.6004/jnccn.2012.0084

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN： 1540-1405            Impact factor:   11.908


× No keyword cloud information.
  28 in total

1.  Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck.

Authors:  Jay S Cooper; Thomas F Pajak; Arlene A Forastiere; John Jacobs; Bruce H Campbell; Scott B Saxman; Julie A Kish; Harold E Kim; Anthony J Cmelak; Marvin Rotman; Mitchell Machtay; John F Ensley; K S Clifford Chao; Christopher J Schultz; Nancy Lee; Karen K Fu
Journal:  N Engl J Med       Date:  2004-05-06       Impact factor: 91.245

2.  Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer.

Authors:  Jacques Bernier; Christian Domenge; Mahmut Ozsahin; Katarzyna Matuszewska; Jean-Louis Lefèbvre; Richard H Greiner; Jordi Giralt; Philippe Maingon; Frédéric Rolland; Michel Bolla; Francesco Cognetti; Jean Bourhis; Anne Kirkpatrick; Martine van Glabbeke
Journal:  N Engl J Med       Date:  2004-05-06       Impact factor: 91.245

Review 3.  Cancers with increasing incidence trends in the United States: 1999 through 2008.

Authors:  Edgar P Simard; Elizabeth M Ward; Rebecca Siegel; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2012-01-04       Impact factor: 508.702

4.  Cigarette smoking among adults--United States, 1993.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1994-12-23       Impact factor: 17.586

5.  Evidence for a causal association between human papillomavirus and a subset of head and neck cancers.

Authors:  M L Gillison; W M Koch; R B Capone; M Spafford; W H Westra; L Wu; M L Zahurak; R W Daniel; M Viglione; D E Symer; K V Shah; D Sidransky
Journal:  J Natl Cancer Inst       Date:  2000-05-03       Impact factor: 13.506

6.  Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial.

Authors:  Danny Rischin; Richard J Young; Richard Fisher; Stephen B Fox; Quynh-Thu Le; Lester J Peters; Ben Solomon; Jimin Choi; Brian O'Sullivan; Lizbeth M Kenny; Grant A McArthur
Journal:  J Clin Oncol       Date:  2010-08-09       Impact factor: 44.544

7.  Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial.

Authors:  Christopher M Nutting; James P Morden; Kevin J Harrington; Teresa Guerrero Urbano; Shreerang A Bhide; Catharine Clark; Elizabeth A Miles; Aisha B Miah; Kate Newbold; MaryAnne Tanay; Fawzi Adab; Sarah J Jefferies; Christopher Scrase; Beng K Yap; Roger P A'Hern; Mark A Sydenham; Marie Emson; Emma Hall
Journal:  Lancet Oncol       Date:  2011-01-12       Impact factor: 41.316

8.  Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus.

Authors:  Boudewijn J M Braakhuis; Peter J F Snijders; Willem-Jan H Keune; Chris J L M Meijer; Henrique J Ruijter-Schippers; C René Leemans; Ruud H Brakenhoff
Journal:  J Natl Cancer Inst       Date:  2004-07-07       Impact factor: 13.506

Review 9.  The role of human papillomavirus in oral carcinogenesis.

Authors:  Patrick K Ha; Joseph A Califano
Journal:  Crit Rev Oral Biol Med       Date:  2004-07-01

10.  Comprehensive irradiation of head and neck cancer using conformal multisegmental fields: assessment of target coverage and noninvolved tissue sparing.

Authors:  A Eisbruch; L H Marsh; M K Martel; J A Ship; R Ten Haken; A T Pu; B A Fraass; A S Lichter
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-06-01       Impact factor: 7.038
View more
  16 in total

Review 1.  The emerging role of immunotherapy in head and neck squamous cell carcinoma (HNSCC): anti-tumor immunity and clinical applications.

Authors:  Panagiota Economopoulou; Christos Perisanidis; Evaggelos I Giotakis; Amanda Psyrri
Journal:  Ann Transl Med       Date:  2016-05

2.  Impaired H3K36 methylation defines a subset of head and neck squamous cell carcinomas.

Authors:  Simon Papillon-Cavanagh; Chao Lu; Tenzin Gayden; Leonie G Mikael; Denise Bechet; Christina Karamboulas; Laurie Ailles; Jason Karamchandani; Dylan M Marchione; Benjamin A Garcia; Ilan Weinreb; David Goldstein; Peter W Lewis; Octavia Maria Dancu; Sandeep Dhaliwal; William Stecho; Christopher J Howlett; Joe S Mymryk; John W Barrett; Anthony C Nichols; C David Allis; Jacek Majewski; Nada Jabado
Journal:  Nat Genet       Date:  2017-01-09       Impact factor: 38.330

Review 3.  Activated HGF-c-Met Axis in Head and Neck Cancer.

Authors:  Levi Arnold; Jonathan Enders; Sufi Mary Thomas
Journal:  Cancers (Basel)       Date:  2017-12-12       Impact factor: 6.575

Review 4.  The promise of immunotherapy in head and neck squamous cell carcinoma: combinatorial immunotherapy approaches.

Authors:  Panagiota Economopoulou; Ioannis Kotsantis; Amanda Psyrri
Journal:  ESMO Open       Date:  2017-02-13

5.  The use of fentanyl in pain management in head and neck cancer patients: a narrative review.

Authors:  Raffaele Giusti; Paolo Bossi; Marco Mazzotta; Marco Filetti; Daniela Iacono; Paolo Marchetti
Journal:  Br J Pain       Date:  2017-10-10

6.  Integrative analysis of the microRNA-mRNA response to radiochemotherapy in primary head and neck squamous cell carcinoma cells.

Authors:  Isolde Summerer; Julia Hess; Adriana Pitea; Kristian Unger; Ludwig Hieber; Martin Selmansberger; Kirsten Lauber; Horst Zitzelsberger
Journal:  BMC Genomics       Date:  2015-09-02       Impact factor: 3.969

Review 7.  Head and neck cancer: improving outcomes with a multidisciplinary approach.

Authors:  Cristiana Lo Nigro; Nerina Denaro; Anna Merlotti; Marco Merlano
Journal:  Cancer Manag Res       Date:  2017-08-18       Impact factor: 3.989

Review 8.  ROS-Mediated Therapeutic Strategy in Chemo-/Radiotherapy of Head and Neck Cancer.

Authors:  Gan Huang; Shu-Ting Pan
Journal:  Oxid Med Cell Longev       Date:  2020-07-22       Impact factor: 6.543

9.  Prognostic impact of indoleamine 2,3-dioxygenase 1 (IDO1) mRNA expression on circulating tumour cells of patients with head and neck squamous cell carcinoma.

Authors:  Panagiota Economopoulou; Athina Kladi-Skandali; Areti Strati; George Koytsodontis; Efthymios Kirodimos; Evangelos Giotakis; Pavlos Maragoudakis; Eleni Gagari; Eirini Maratou; George Dimitriadis; Ioannis Kotsantis; Elena Vagia; Maria Anastasiou; Maria Gkotzamanidou; George Kavourakis; Evi Lianidou; Amanda Psyrri
Journal:  ESMO Open       Date:  2020-05

10.  Treatment-naïve HPV+ head and neck cancers display a T-cell-inflamed phenotype distinct from their HPV- counterparts that has implications for immunotherapy.

Authors:  Steven F Gameiro; Farhad Ghasemi; John W Barrett; James Koropatnick; Anthony C Nichols; Joe S Mymryk; Saman Maleki Vareki
Journal:  Oncoimmunology       Date:  2018-07-30       Impact factor: 8.110
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.